ANEBULO PHARMACEUTICALS INC (ANEB)
Institutional ownership reported to the SEC as of Q4 2025, across 19 quarters.
17
Reporting holders
$91.6M
Reported value
54.5%
Of shares outstanding
0.0%
Held as options
-3
Holder change
Institutions report 22,208,686 shares against 40,784,731 outstanding. Shares only - option lines are excluded, which is why this can be compared with the company at all. The count comes from the cover page of the company's own most recent report, so it is dated when that was filed rather than at quarter end.
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| 22NW, LP | $84.8M | 15,467,300 | 35.68% | 19q | HELD |
| Nantahala Capital Management, LLC | $3.1M | 3,036,325 | 0.10% | 14q | HELD |
| MANGROVE PARTNERS IM, LLC | $2.6M | 2,525,252 | 0.21% | 5q | HELD |
| VANGUARD GROUP INC | $440.2K | 435,821 | 0.00% | 11q | +42.2%+$130.6K |
| MORGAN STANLEY | $403.4K | 399,404 | 0.00% | 9q | HELD |
| GEODE CAPITAL MANAGEMENT, LLC | $162.5K | 160,760 | 0.00% | 8q | -7.7%-$13.5K |
| Rangeley Capital, LLC | $50.5K | 50,000 | 0.04% | 2q | +150.0%+$30.3K |
| RENAISSANCE TECHNOLOGIES LLC | $25.3K | 25,098 | 0.00% | 2q | -11.9%-$3.4K |
| CITADEL ADVISORS LLC | $24.5K | 24,239 | 0.00% | new | NEW |
| BlackRock, Inc. | $24.0K | 23,790 | 0.00% | 6q | -1.1% |
| NORTHERN TRUST CORP | $22.2K | 21,994 | 0.00% | 2q | -9.8%-$2.4K |
| Ikarian Capital, LLC | $17.9K | 17,736 | 0.00% | 19q | -88.8%-$141.4K |
| STATE STREET CORP | $12.9K | 12,768 | 0.00% | 2q | HELD |
| Tower Research Capital LLC (TRC) | $3.3K | 3,230 | 0.00% | 16q | +84.6%+$1.5K |
| UBS Group AG | $2.4K | 2,334 | 0.00% | 6q | +960.9%+$2.1K |
| JPMORGAN CHASE & CO | $2.3K | 2,253 | 0.00% | 2q | -47.3%-$2.0K |
| BANK OF AMERICA CORP /DE/ | $386 | 382 | 0.00% | 7q | -57.1% |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q4 2025 | 17 | $91.6M | 22,208,686 | 1 | 4 | 7 | 0.0% |
| Q3 2025 | 20 | $55.6M | 22,221,901 | 8 | 3 | 3 | 0.0% |
| Q2 2025 | 18 | $32.5M | 22,591,946 | 2 | 5 | 3 | 0.0% |
| Q1 2025 | 17 | $29.4M | 22,595,080 | 3 | 5 | 4 | 0.0% |
| Q4 2024 | 15 | $37.3M | 22,570,347 | 2 | 6 | 4 | 0.0% |
| Q3 2024 | 13 | $14.2M | 7,343,743 | 1 | 2 | 3 | 0.0% |
| Q2 2024 | 12 | $21.3M | 7,818,861 | 1 | 3 | 3 | 0.0% |
| Q1 2024 | 14 | $23.3M | 8,104,812 | 4 | 2 | 3 | 0.0% |
| Q4 2023 | 13 | $19.8M | 8,189,285 | 3 | 4 | 3 | 0.0% |
| Q3 2023 | 11 | $21.6M | 7,050,491 | 0 | 5 | 2 | 0.0% |
| Q2 2023 | 11 | $16.5M | 7,031,883 | 2 | 2 | 1 | 0.0% |
| Q1 2023 | 8 | $19.8M | 6,831,023 | 0 | 2 | 0 | 0.0% |
| Q4 2022 | 11 | $17.1M | 7,042,710 | 1 | 1 | 1 | 0.0% |
| Q3 2022 | 10 | $19.2M | 6,842,912 | 2 | 2 | 4 | 0.0% |
| Q2 2022 | 8 | $24.3M | 4,677,847 | 1 | 2 | 1 | 0.0% |
| Q1 2022 | 8 | $29.5M | 4,190,412 | 1 | 2 | 3 | 0.0% |
| Q4 2021 | 8 | $25.8M | 4,193,307 | 1 | 2 | 2 | 0.0% |
| Q3 2021 | 7 | $27.5M | 4,183,214 | 0 | 1 | 4 | 0.0% |
| Q2 2021 | 8 | $28.7M | 4,199,813 | 8 | 0 | 0 | 0.0% |